KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Guardant Health (GH) Receivables - Other (2019 - 2025)

Historic Receivables - Other for Guardant Health (GH) over the last 7 years, with Q3 2025 value amounting to $5.1 million.

  • Guardant Health's Receivables - Other rose 1086.96% to $5.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.1 million, marking a year-over-year increase of 1086.96%. This contributed to the annual value of $3.4 million for FY2024, which is 3061.22% down from last year.
  • Guardant Health's Receivables - Other amounted to $5.1 million in Q3 2025, which was up 1086.96% from $3.8 million recorded in Q2 2025.
  • Over the past 5 years, Guardant Health's Receivables - Other peaked at $30.9 million during Q3 2021, and registered a low of $3.1 million during Q1 2022.
  • In the last 5 years, Guardant Health's Receivables - Other had a median value of $4.9 million in 2022 and averaged $7.8 million.
  • As far as peak fluctuations go, Guardant Health's Receivables - Other soared by 30714.29% in 2021, and later plummeted by 8349.51% in 2022.
  • Quarter analysis of 5 years shows Guardant Health's Receivables - Other stood at $5.7 million in 2021, then decreased by 5.26% to $5.4 million in 2022, then decreased by 9.26% to $4.9 million in 2023, then tumbled by 30.61% to $3.4 million in 2024, then surged by 50.0% to $5.1 million in 2025.
  • Its last three reported values are $5.1 million in Q3 2025, $3.8 million for Q2 2025, and $4.2 million during Q1 2025.